They avoid needles, which is a plus for many
(2021) reported lower Clostridium group IV in PD as well as no strongly associated taxa with levodopa (L-DOPA) use, although preliminary data suggest Clostridium cluster IV may be linked to short-term motor-symptom response to L-DOPA, which deserves a thorough controlled validation
Then came a glimmer of hope: In January 2024, her gynecologist suggested Zepbound (LLY), one of the GLP-1 medications proving remarkably effective at treating a host of conditions, including managing PCOS symptoms
Clinical trials show that 4-week GLP-1 treatment produces weight loss, but studies lasting 12-52 weeks demonstrate that sustained therapy achieves 15-22% body weight reduction compared to 5-8% in the first month
Tirzepatide induces weight loss in patients with type 2 diabetes regardless of baseline BMI: a post hoc analysis of SURPASS-1 through -5 studies (abstract)
GLP-1 medications offer a way to jumpstart weight loss for new moms who feel stuck